Probiotics and prebiotic fiber for constipation associated with Parkinson disease

Neurology

Volumn 87, Issue 12, 2016, Pages 1274-1280

  Barichella, Michela ^a   Pacchetti, Claudio ^b   Bolliri, Carlotta ^a   Cassani, Erica ^a   Iorio, Laura ^a   Pusani, Chiara ^a   Pinelli, Giovanna ^a   Privitera, Giulia ^a   Cesari, Ilaria ^a   Faierman, Samanta Andrea ^a   Caccialanza, Riccardo ^c   Pezzoli, Gianni ^a   Cereda, Emanuele ^c  

^a PARKINSON INSTITUTE   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

AGED; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; FEMALE; FERMENTED PRODUCT; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; ANIMAL; COMPLICATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; OUTPATIENT; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTER; TREATMENT OUTCOME;

AGED; ANIMALS; CONSTIPATION; DEFECATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MILK; OUTPATIENTS; PARKINSON DISEASE; PATIENT SATISFACTION; PREBIOTICS; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84988531129     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003127     Document Type: Article

References (27)

1. Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009;24:1881-1892.
2. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2015;14:625-639.
3. Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson's disease. Mov Disord 2015;30:1600-1611.
4. Keshavarzian A, Green SJ, Engen PA, et al. Colonic bacterial composition in Parkinson's disease. Mov Disord 2015;30:1351-1360.
5. Forsyth CB, Shannon KM, Kordower JH, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 2011;6:e28032.
6. Simrén M, Barbara G, Flint HJ, et al; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-176.
7. Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 2014;146:1554-1563.
8. Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109: 1547-1561; quiz 1546, 1562.
9. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2014;100: 1075-1084.
10. Rossi M, Merello M, Perez-Lloret S. Management of constipation in Parkinson's disease. Expert Opin Pharmacother 2015;16:547-557.
11. Zangaglia R, Martignoni E, Glorioso M, et al. Macrogol for the treatment of constipation in Parkinson's disease: a randomized placebo-controlled study. Mov Disord 2007; 22:1239-1244.
12. Ondo WG, Kenney C, Sullivan K, et al. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology 2012;78:1650-1654.
13. Bharucha AE, Pemberton JH, Locke GR III. American Gastroenterological Association technical review on constipation. Gastroenterology 2013;144:218-238.
14. Cassani E, Privitera G, Pezzoli G, et al. Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol Dietol 2011;57:117-121.
15. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improves the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001;57:S34-S38.
16. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130: 1377-1390.
17. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32: 920-924.
18. Fahn S, Elton RL; UPDRS Program Members. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent Developments in Parkinson's Disease, Vol. 2. Florham Park: Macmillan Healthcare Information; 1987:153-163, 293-304.
19. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
20. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-399.
21. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota host health: a new clinical frontier. Gut 2015;65: 330-339. doi: 10.1136/gutjnl-2015-309990.
22. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 2011;50:1-17.
23. Lebouvier T, Chaumette T, Damier P, et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008;57:1741-1743.
24. Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 2014;128: 805-820.
25. Corazziari E, Bytzer P, Delvaux M, et al. Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:569-580.
26. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-1551.
27. Evatt ML, Chaudhuri KR, Chou KL, et al. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation-critique and recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease. Mov Disord 2009;24: 635-646.